ICPMS-2040 Series / ICPMS-2050 Series
- Simultaneous qualitative scanning feature benefits to user in identification of non-targeted elements, supporting the creation of a comprehensive extractable profile. - Proprietary Mini-Torch technology enables stable plasma with higher sensitivity and lower gas consumption (11 L/min). - LabSolutions ICPMS ensures compliance with regulatory norms in spectroscopy products, streamlining data management.
Extractable and leachable (E & L) studies are becoming increasingly important in the pharmaceutical industry as it is a mandatory requirement from the FDA during filing of the drug product. The purpose of E & L studies is to identify and evaluate possible toxicological risks. In this, the regulatory references aim to identify traces of potential chemical substances. These substances may be harmful to patients due to their toxicity or may impact the activity of the drug product. Hence, to ensure the safety and efficacy of the drug throughout its shelf-life, E & L studies play an important role.
September 30, 2026 GMT
Some products may be updated to newer models